Cited by 7Effects and risks of endocrine disrupting chemicalsEpigenetics and DNA MethylationSexual Differentiation and Disorders

The invisible influence: can endocrine disruptors reshape behaviors across generations?

Open access
Damiano, Antonella, Caioni, Giulia, D’Addario, Claudio, Merola, Carmine, Francioso, Antonio, Amorena, Michele·2025·Stresses

Abstract

Among the numerous compounds released as a result of human activities, endocrine-disrupting chemicals (EDCs) have attracted particular attention due to their widespread detection in human biological samples and their accumulation across various ecosystems. While early research primarily focused on their effects on reproductive health, it is now evident that EDCs may impact neurodevelopment, altering the integrity of neural circuits essential for cognitive abilities, emotional regulation, and social behaviors. These compounds may elicit epigenetic modifications, such as DNA methylation and histone acetylation, that result in altered expression patterns, potentially affecting multiple generations and contribute to long-term behavioral phenotypes. The effects of EDCs may occur though both direct and indirect mechanisms, ultimately converging on neurodevelopmental vulnerability. In particular, the gut–brain axis has emerged as a critical interface targeted by EDCs. This bidirectional communication network integrates the nervous, immune, and endocrine systems. By altering the microbiota composition, modulating immune responses, and triggering epigenetic mechanisms, EDCs can act on multiple and interconnected pathways. In this context, elucidating the impact of EDCs on neurodevelopmental processes is crucial for advancing our understanding of their contribution to neurological and behavioral health risks.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/stresses5030046

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Sex steroids, thyroid hormones, and glucocorticoids modulate synaptic transmission, dendritic spine dynamics, neuronal excitability, and circuit maturation, particularly in the hippocampus and hypothalamus.

    “Sex steroids, thyroid hormones, and glucocorticoids modulate synaptic transmission, dendritic spine dynamics, neuronal excitability, and circuit maturation, particularly in plasticity-relevant regions such as the hippocampus and hypothalamus (Damiano et al., 2025; Dos-Santos et al., 2023; Dsouki et al., 2024; Ogiue-Ikeda et al., 2008; Pang and Han, 2012; Parent et al., 2011; Weiss, 2007).”

    From Environmental endocrine disruptors at the synapse: mechanisms linking chemical exposure to cognitive and behavioral dysfunction (2026) · cites this paper as Damiano et al., 2025

    Section 2 links thyroid hormones to synaptogenesis and neural circuit formation, and estrogen receptors to synaptic plasticity. Section 3.1 discusses glucocorticoid-related changes in hippocampal receptor expression, but the paper does not establish that all three hormone classes modulate synaptic transmission, dendritic spine dynamics, and neuronal excitability, particularly in both the hippocampus and hypothalamus. Page numbers are unavailable in our copy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • PBDEs are persistent and lipophilic, and due to regulatory restrictions are increasingly replaced by OPFRs, which are not harmless.

    “Among the most prominent representatives are polybrominated diphenyl ethers (PBDEs), which are characterized by their persistence and lipophilic nature. Due to regulatory restrictions, PBDEs are increasingly being replaced by organophosphate flame retardants (OPFRs), which are by no means harmless (Damiano et al., 2025; Dsouki et al., 2024; Rojas et al., 2025).”

    From Environmental endocrine disruptors at the synapse: mechanisms linking chemical exposure to cognitive and behavioral dysfunction (2026) · cites this paper as Damiano et al., 2025

    Section 2 identifies PBDEs as flame retardants and links exposure to thyroid-disease risk; Section 4 reports an association between PBDE exposure and impaired verbal comprehension. These passages support concern about PBDEs, but our copy does not describe them as persistent or lipophilic, or say that regulatory restrictions are driving their replacement by OPFRs or that OPFRs are harmful (searched: OPFR, organophosphate, replacement). No page numbers were available in the indexed passages. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • In adult male mice, six-week oral exposure to low doses of DEHP alone or in an environmental phthalate mixture increased BBB permeability in the hypothalamic medial preoptic area and in the hippocampal CA1 and CA3 regions, accompanied by altered expression of zona occludens-1 and Cav-1, as well as local glial activation.

    “In adult male mice, six-week oral exposure to low doses of DEHP alone or in an environmental phthalate mixture increased BBB permeability in the hypothalamic medial preoptic area and in the hippocampal CA1 and CA3 regions, accompanied by altered expression of the tight-junction-associated protein zona occludens-1 and caveolae protein Cav-1, as well as local glial activation (Ahmadpour et al., 2021”

    From Environmental endocrine disruptors at the synapse: mechanisms linking chemical exposure to cognitive and behavioral dysfunction (2026) · cites this paper as Damiano et al., 2025

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Barrier impairment facilitates the entry of peripheral immune mediators and other harmful substances into vulnerable brain regions, reinforcing neuroinflammatory and neurotoxic cascades.

    “Such barrier impairment is mechanistically significant because it facilitates the entry of peripheral immune mediators and other harmful substances into vulnerable brain regions, thereby reinforcing neuroinflammatory and neurotoxic cascades (Ahmadpour et al., 2021; Damiano et al., 2025).”

    From Environmental endocrine disruptors at the synapse: mechanisms linking chemical exposure to cognitive and behavioral dysfunction (2026) · cites this paper as Damiano et al., 2025

    Section 2 (page not indicated) says endocrine-disrupting chemicals may increase blood–brain barrier permeability, allowing peripheral immune cells and harmful substances into the brain and exacerbating neurodevelopmental and neurodegenerative risks. It does not specifically say peripheral immune mediators enter or that their entry reinforces neuroinflammatory and neurotoxic cascades; the citing sentence also states a tentative mechanism more definitively. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • The close integration of synaptic and endocrine signaling renders the CNS particularly vulnerable to EDCs.

    “This close integration of synaptic and endocrine signaling renders the CNS particularly vulnerable to EDCs, which are exogenous substances or mixtures that interfere with endocrine function and thereby cause adverse effects in exposed organisms or their offspring (Damiano et al., 2025; Gilbert et al., 2020; Klyubin et al., 2022; Schug et al., 2015).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 127

  1. Chormare, R.; Kumar, M.A. Environmental Health and Risk Assessment Metrics with Special Mention to Biotransfer, Bioaccumu- lation and Biomagnification of Environmental Pollutants. Chemosphere 2022, 302, 134836. [CrossRef] · DOI
  2. Khan, S.; Naushad, M.; Govarthanan, M.; Iqbal, J.; Alfadul, S.M. Emerging Contaminants of High Concern for the Environment: Current Trends and Future Research. Environ. Res. 2022, 207, 112609. [CrossRef] · DOI
  3. Fortenberry, G.Z.; Meeker, J.D.; Sánchez, B.N.; Barr, D.B.; Panuwet, P.; Bellinger, D.; Schnaas, L.; Solano-González, M.; Ettinger, A.S.; Hernandez-Avila, M.; et al. Urinary 3, 5, 6-Trichloro-2-Pyridinol (TCPY) in Pregnant Women from Mexico City: Distribution, Temporal Variability, and Relationship with Child Attention and Hyperactivity. Int. J. Hyg. Environ. Health 2014, 217, 405-412. [CrossRef] · DOI
  4. Maitre, L.; Robinson, O.; Martinez, D.; Toledano, M.B.; Ibarluzea, J.; Marina, L.S.; Sunyer, J.; Villanueva, C.M.; Keun, H.C.; Vrijheid, M.; et al. Urine Metabolic Signatures of Multiple Environmental Pollutants in Pregnant Women: An Exposome Approach. Environ. Sci. Technol. 2018, 52, 13469-13480. [CrossRef] [PubMed] · DOI
  5. Merrill, A.K.; Sobolewski, M.; Susiarjo, M. Exposure to Endocrine Disrupting Chemicals Impacts Immunological and Metabolic Status of Women during Pregnancy. Mol. Cell. Endocrinol. 2023, 577, 112031. [CrossRef] [PubMed] · DOI
  6. Rizzo, R.; Bortolotti, D.; Rizzo, S.; Schiuma, G. Endocrine Disruptors, Epigenetic Changes, and Transgenerational Transmission. In Environment Impact on Reproductive Health: A Translational Approach; Marci, R., Ed.; Springer International Publishing: Cham, Switzerland, 2023; pp. 49-74; ISBN 978-3-031-36494-5.
  7. Demirtaş, ˙I.; Mızık, E.T.; Can-Güven, E.; Gedik, K. A Data-Driven Analysis of Global Research Trends on Dirty-Dozen Persistent Organic Pollutants. Environ. Monit. Assess. 2023, 195, 1115. [CrossRef] · DOI
  8. Guillotin, S.; Delcourt, N. Studying the Impact of Persistent Organic Pollutants Exposure on Human Health by Proteomic Analysis: A Systematic Review. Int. J. Mol. Sci. 2022, 23, 14271. [CrossRef] · DOI
  9. Grasselli, E.; Dvorakova, M.; Graceli, J.B. Editorial: Presence and Daily Exposure to Endocrine Disruptors: How Can Human Life Change? Front. Endocrinol. 2021, 12, 790853. [CrossRef] · DOI
  10. Kabir, E.R.; Rahman, M.S.; Rahman, I. A Review on Endocrine Disruptors and Their Possible Impacts on Human Health. Environ. Toxicol. Pharmacol. 2015, 40, 241-258. [CrossRef] · DOI · Paper page
  11. Yilmaz, B.; Terekeci, H.; Sandal, S.; Kelestimur, F. Endocrine Disrupting Chemicals: Exposure, Effects on Human Health, Mechanism of Action, Models for Testing and Strategies for Prevention. Rev. Endocr. Metab. Disord. 2020, 21, 127-147. [CrossRef] · DOI
  12. Masi, M.; Racchi, M.; Travelli, C.; Corsini, E.; Buoso, E. Molecular Characterization of Membrane Steroid Receptors in Hormone- Sensitive Cancers. Cells 2021, 10, 2999. [CrossRef] [PubMed] · DOI
  13. Chen, Y.; Lin, M.; Zhuang, D. Wastewater Treatment and Emerging Contaminants: Bibliometric Analysis. Chemosphere 2022, 297, 133932. [CrossRef] [PubMed] · DOI
  14. Kelley, A.S.; Banker, M.; Goodrich, J.M.; Dolinoy, D.C.; Burant, C.; Domino, S.E.; Smith, Y.R.; Song, P.X.K.; Padmanabhan, V. Early Pregnancy Exposure to Endocrine Disrupting Chemical Mixtures Are Associated with Inflammatory Changes in Maternal and Neonatal Circulation. Sci. Rep. 2019, 9, 5422. [CrossRef] [PubMed] · DOI
  15. Rolfo, A.; Nuzzo, A.M.; De Amicis, R.; Moretti, L.; Bertoli, S.; Leone, A. Fetal-Maternal Exposure to Endocrine Disruptors: Correlation with Diet Intake and Pregnancy Outcomes. Nutrients 2020, 12, 1744. [CrossRef] · DOI
  16. Shekhar, S.; Sood, S.; Showkat, S.; Lite, C.; Chandrasekhar, A.; Vairamani, M.; Barathi, S.; Santosh, W. Detection of Phenolic Endocrine Disrupting Chemicals (EDCs) from Maternal Blood Plasma and Amniotic Fluid in Indian Population. Gen. Comp. Endocrinol. 2017, 241, 100-107. [CrossRef] · DOI
  17. Tang, Z.-R.; Xu, X.-L.; Deng, S.-L.; Lian, Z.-X.; Yu, K. Oestrogenic Endocrine Disruptors in the Placenta and the Fetus. Int. J. Mol. Sci. 2020, 21, 1519. [CrossRef] · DOI
  18. Svensson, K.; Gennings, C.; Lindh, C.; Kiviranta, H.; Rantakokko, P.; Wikström, S.; Bornehag, C.-G. Prenatal Exposures to Mixtures of Endocrine Disrupting Chemicals and Sex-Specific Associations with Children's BMI and Overweight at 5.5 Years of Age in the SELMA Study. Environ. Int. 2023, 179, 108176. [CrossRef] · DOI
  19. Maddalon, A.; Cari, L.; Iulini, M.; Alhosseini, M.N.; Galbiati, V.; Marinovich, M.; Nocentini, G.; Corsini, E. Impact of Endocrine Disruptors on Peripheral Blood Mononuclear Cells in Vitro: Role of Gender. Arch. Toxicol. 2023, 97, 3129-3150. [CrossRef] · DOI
  20. Maddalon, A.; Masi, M.; Iulini, M.; Linciano, P.; Galbiati, V.; Marinovich, M.; Racchi, M.; Buoso, E.; Corsini, E. Effects of Endocrine Active Contaminating Pesticides on RACK1 Expression and Immunological Consequences in THP-1 Cells. Environ. Toxicol. Pharmacol. 2022, 95, 103971. [CrossRef] · DOI
  21. Buoso, E.; Masi, M.; Racchi, M.; Corsini, E. Endocrine-Disrupting Chemicals' (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1. Int. J. Mol. Sci. 2020, 21, 9229. [CrossRef] [PubMed] · DOI
  22. Buoso, E.; Masi, M.; Long, A.; Chiappini, C.; Travelli, C.; Govoni, S.; Racchi, M. Ribosomes as a Nexus between Translation and Cancer Progression: Focus on Ribosomal Receptor for Activated C Kinase 1 (RACK1) in Breast Cancer. Br. J. Pharmacol. 2022, 179, 2813-2828. [CrossRef] [PubMed] · DOI
  23. Arneth, B. Tumor Microenvironment. Medicina 2019, 56, 15. [CrossRef] · DOI
  24. Brehm, E.; Flaws, J.A. Transgenerational Effects of Endocrine-Disrupting Chemicals on Male and Female Reproduction. En- docrinology 2019, 160, 1421-1435. [CrossRef] · DOI
  25. Siracusa, J.S.; Yin, L.; Measel, E.; Liang, S.; Yu, X. Effects of Bisphenol A and Its Analogs on Reproductive Health: A Mini Review. Reprod. Toxicol. 2018, 79, 96-123. [CrossRef] · DOI
  26. Wang, W.; Hafner, K.S.; Flaws, J.A. In Utero Bisphenol A Exposure Disrupts Germ Cell Nest Breakdown and Reduces Fertility with Age in the Mouse. Toxicol. Appl. Pharmacol. 2014, 276, 157-164. [CrossRef] · DOI
  27. Wisniewski, P.; Romano, R.M.; Kizys, M.M.L.; Oliveira, K.C.; Kasamatsu, T.; Giannocco, G.; Chiamolera, M.I.; Dias-da-Silva, M.R.; Romano, M.A. Adult Exposure to Bisphenol A (BPA) in Wistar Rats Reduces Sperm Quality with Disruption of the Hypothalamic-Pituitary-Testicular Axis. Toxicology 2015, 329, 1-9. [CrossRef] · DOI
  28. Heindel, J.J.; Blumberg, B.; Cave, M.; Machtinger, R.; Mantovani, A.; Mendez, M.A.; Nadal, A.; Palanza, P.; Panzica, G.; Sargis, R.; et al. Metabolism Disrupting Chemicals and Metabolic Disorders. Reprod. Toxicol. 2017, 68, 3-33. [CrossRef] · DOI · Paper page
  29. Aronica, L.; Ordovas, J.M.; Volkov, A.; Lamb, J.J.; Stone, P.M.; Minich, D.; Leary, M.; Class, M.; Metti, D.; Larson, I.A.; et al. Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine. Nutrients 2022, 14, 768. [CrossRef] · DOI
  30. Bornman, M.; Delport, R.; Farías, P.; Aneck-Hahn, N.; Patrick, S.; Millar, R.P.; de Jager, C. Alterations in Male Reproductive Hormones in Relation to Environmental DDT Exposure. Environ. Int. 2018, 113, 281-289. [CrossRef] [PubMed] · DOI
  31. Czarnywojtek, A.; Jaz, K.; Ochma ńska, A.; Zgorzalewicz-Stachowiak, M.; Czarnocka, B.; Sawicka-Gutaj, N.; Ziółkowska, P.; Krela-Kaźmierczak, I.; Gut, P.; Florek, E.; et al. The Effect of Endocrine Disruptors on the Reproductive System-Current Knowledge. Eur. Rev. Med. Pharmacol. Sci. 2021, 25, 4930-4940. [CrossRef] [PubMed] · DOI
  32. Jarman, W.M.; Ballschmiter, K. From Coal to DDT: The History of the Development of the Pesticide DDT from Synthetic Dyes till Silent Spring. Endeavour 2012, 36, 131-142. [CrossRef] · DOI
  33. Jeng, H.A. Exposure to Endocrine Disrupting Chemicals and Male Reproductive Health. Front. Public Health 2014, 2, 55. [CrossRef] · DOI
  34. McCue, K.; DeNicola, N. Environmental Exposures in Reproductive Health. Obstet. Gynecol. Clin. N. Am. 2019, 46, 455-468. [CrossRef] · DOI
  35. Braun, J.M. Early-Life Exposure to EDCs: Role in Childhood Obesity and Neurodevelopment. Nat. Rev. Endocrinol. 2017, 13, 161-173. [CrossRef] · DOI
  36. Rich, A.L.; Phipps, L.M.; Tiwari, S.; Rudraraju, H.; Dokpesi, P.O. The Increasing Prevalence in Intersex Variation from Toxicological Dysregulation in Fetal Reproductive Tissue Differentiation and Development by Endocrine-Disrupting Chemicals. Environ. Health Insights 2016, 10, 163-171. [CrossRef] · DOI
  37. Schwarzman, M. Potential Toxicity of Synthetic Chemicals: What You Should Know about Endocrine-Disrupting Chemicals. Am. Fam. Physician 2008, 78, 565-566.
  38. Almstrup, K.; Frederiksen, H.; Andersson, A.-M.; Juul, A. Levels of Endocrine-Disrupting Chemicals Are Associated with Changes in the Peri-Pubertal Epigenome. Endocr. Connect. 2020, 9, 845-857. [CrossRef] · DOI
  39. Nettore, I.C.; Franchini, F.; Palatucci, G.; Macchia, P.E.; Ungaro, P. Epigenetic Mechanisms of Endocrine-Disrupting Chemicals in Obesity. Biomedicines 2021, 9, 1716. [CrossRef] · DOI
  40. Panera, N.; Mandato, C.; Crudele, A.; Bertrando, S.; Vajro, P.; Alisi, A. Genetics, Epigenetics and Transgenerational Transmission of Obesity in Children. Front. Endocrinol. 2022, 13, 1006008. [CrossRef] [PubMed] · DOI
  41. Samtani, R.; Sharma, N.; Garg, D. Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review. Reprod. Sci. 2018, 25, 7-18. [CrossRef] [PubMed] · DOI
  42. Cediel-Ulloa, A.; Lupu, D.L.; Johansson, Y.; Hinojosa, M.; Özel, F.; Rüegg, J. Impact of Endocrine Disrupting Chemicals on Neurodevelopment: The Need for Better Testing Strategies for Endocrine Disruption-Induced Developmental Neurotoxicity. Expert. Rev. Endocrinol. Metab. 2022, 17, 131-141. [CrossRef] · DOI
  43. Montero-Pedrazuela, A.; Grijota-Martínez, C.; Ausó, E.; Bárez-López, S.; Guadaño-Ferraz, A. Chapter 8-Endocrine Aspects of Development. Thyroid Hormone Actions in Neurological Processes during Brain Development. In Diagnosis, Management and Modeling of Neurodevelopmental Disorders;
  44. Makris, G.; Eleftheriades, A.; Pervanidou, P. Early Life Stress, Hormones, and Neurodevelopmental Disorders. Horm. Res. Paediatr. 2023, 96, 17-24. [CrossRef] [PubMed] · DOI
  45. Anifantaki, F.; Pervanidou, P.; Lambrinoudaki, I.; Panoulis, K.; Vlahos, N.; Eleftheriades, M. Maternal Prenatal Stress, Thyroid Function and Neurodevelopment of the Offspring: A Mini Review of the Literature. Front. Neurosci. 2021, 15, 692446. [CrossRef] · DOI
  46. Bludau, A.; Royer, M.; Meister, G.; Neumann, I.D.; Menon, R. Epigenetic Regulation of the Social Brain. Trends Neurosci. 2019, 42, 471-484. [CrossRef] · DOI
  47. Manley, K.; Han, W.; Zelin, G.; Lawrence, D.A. Crosstalk between the Immune, Endocrine, and Nervous Systems in Immunotoxi- cology. Curr. Opin. Toxicol. 2018, 10, 37-45. [CrossRef] · DOI
  48. Wang, C.; He, T.; Qin, J.; Jiao, J.; Ji, F. The Roles of Immune Factors in Neurodevelopment. Front. Cell. Neurosci. 2025, 19, 1451889. [CrossRef] · DOI
  49. Kajta, M.; Wójtowicz, A.K. Impact of Endocrine-Disrupting Chemicals on Neural Development and the Onset of Neurological Disorders. Pharmacol. Rep. 2013, 65, 1632-1639. [CrossRef] · DOI · Paper page
  50. Li, L.-X.; Chen, L.; Meng, X.-Z.; Chen, B.-H.; Chen, S.-Q.; Zhao, Y.; Zhao, L.-F.; Liang, Y.; Zhang, Y.-H. Exposure Levels of Environmental Endocrine Disruptors in Mother-Newborn Pairs in China and Their Placental Transfer Characteristics. PLoS ONE 2013, 8, e62526. [CrossRef] [PubMed] · DOI
  51. Pérez-Albaladejo, E.; Fernandes, D.; Lacorte, S.; Porte, C. Comparative Toxicity, Oxidative Stress and Endocrine Disruption Potential of Plasticizers in JEG-3 Human Placental Cells. Toxicol. Vitr. 2017, 38, 41-48. [CrossRef] [PubMed] · DOI
  52. Roncati, L.; Piscioli, F.; Pusiol, T. The Endocrine Disruptors among the Environmental Risk Factors for Stillbirth. Sci. Total Environ. 2016, 563-564, 1086-1087. [CrossRef] [PubMed] · DOI
  53. Vizcaino, E.; Grimalt, J.O.; Fernández-Somoano, A.; Tardon, A. Transport of Persistent Organic Pollutants across the Human Placenta. Environ. Int. 2014, 65, 107-115. [CrossRef] · DOI
  54. Mao, J.; Jain, A.; Denslow, N.D.; Nouri, M.-Z.; Chen, S.; Wang, T.; Zhu, N.; Koh, J.; Sarma, S.J.; Sumner, B.W.; et al. Bisphenol A and Bisphenol S Disruptions of the Mouse Placenta and Potential Effects on the Placenta-Brain Axis. Proc. Natl. Acad. Sci. USA 2020, 117, 4642-4652. [CrossRef] · DOI
  55. Forger, N.G. Cell Death and Sexual Differentiation of the Nervous System. Neuroscience 2006, 138, 929-938. [CrossRef] · DOI
  56. McCarthy, M.M.; Auger, A.P.; Bale, T.L.; De Vries, G.J.; Dunn, G.A.; Forger, N.G.; Murray, E.K.; Nugent, B.M.; Schwarz, J.M.; Wilson, M.E. The Epigenetics of Sex Differences in the Brain. J. Neurosci. 2009, 29, 12815-12823. [CrossRef] · DOI
  57. Schug, T.T.; Blawas, A.M.; Gray, K.; Heindel, J.J.; Lawler, C.P. Elucidating the Links between Endocrine Disruptors and Neurodevelopment. Endocrinology 2015, 156, 1941-1951. [CrossRef] · DOI · Paper page
  58. Juricek, L.; Coumoul, X. The Aryl Hydrocarbon Receptor and the Nervous System. Int. J. Mol. Sci. 2018, 19, 2504. [CrossRef] · DOI
  59. Poland, A.; Glover, E.; Kende, A.S. Stereospecific, High Affinity Binding of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin by Hepatic Cytosol. Evidence That the Binding Species Is Receptor for Induction of Aryl Hydrocarbon Hydroxylase. J. Biol. Chem. 1976, 251, 4936-4946. [CrossRef] · DOI · Paper page
  60. Bruner-Tran, K.L.; Gnecco, J.; Ding, T.; Glore, D.R.; Pensabene, V.; Osteen, K.G. Exposure to the Environmental Endocrine Disruptor TCDD and Human Reproductive Dysfunction: Translating Lessons from Murine Models. Reprod. Toxicol. 2017, 68, 59-71. [CrossRef] · DOI
  61. Martin, N.R.; Patel, R.; Kossack, M.E.; Tian, L.; Camarillo, M.A.; Cintrón-Rivera, L.G.; Gawdzik, J.C.; Yue, M.S.; Nwagugo, F.O.; Elemans, L.M.H.; et al. Proper Modulation of AHR Signaling Is Necessary for Establishing Neural Connectivity and Oligodendrocyte Precursor Cell Development in the Embryonic Zebrafish Brain. Front. Mol. Neurosci. 2022, 15, 1032302. [CrossRef] [PubMed] · DOI
  62. Baraka, A.M.; Korish, A.A.; Soliman, G.A.; Kamal, H. The Possible Role of Estrogen and Selective Estrogen Receptor Modulators in a Rat Model of Parkinson's Disease. Life Sci. 2011, 88, 879-885. [CrossRef] [PubMed] · DOI
  63. D'Astous, M.; Morissette, M.; Di Paolo, T. Effect of Estrogen Receptor Agonists Treatment in MPTP Mice: Evidence of Neuropro- tection by an ERα Agonist. Neuropharmacology 2004, 47, 1180-1188. [CrossRef] · DOI
  64. Salama, R.M.; Tadros, M.G.; Schaalan, M.F.; Bahaa, N.; Abdel-tawab, A.M.; Khalifa, A.E. Potential Neuroprotective Effect of Androst-5-ene-3β, 17β-diol (ADIOL) on the Striatum, and Substantia Nigra in Parkinson's Disease Rat Model. J. Cell. Physiol. 2018, 233, 5981-6000. [CrossRef] · DOI
  65. Zhao, L.; Mao, Z.; Chen, S.; Schneider, L.S.; Brinton, R.D. Early Intervention with an Estrogen Receptor β-Selective Phytoestrogenic Formulation Prolongs Survival, Improves Spatial Recognition Memory, and Slows Progression of Amyloid Pathology in a Female Mouse Model of Alzheimer's Disease. J. Alzheimer's Dis. 2013, 37, 403-419. [CrossRef] · DOI
  66. Thambirajah, A.A.; Wade, M.G.; Verreault, J.; Buisine, N.; Alves, V.A.; Langlois, V.S.; Helbing, C.C. Disruption by Stealth- Interference of Endocrine Disrupting Chemicals on Hormonal Crosstalk with Thyroid Axis Function in Humans and Other Animals. Environ. Res. 2022, 203, 111906. [CrossRef] · DOI
  67. Allen, J.G.; Gale, S.; Zoeller, R.T.; Spengler, J.D.; Birnbaum, L.; McNeely, E. PBDE Flame Retardants, Thyroid Disease, and Menopausal Status in U.S. Women. Environ. Health 2016, 15, 60. [CrossRef] · DOI
  68. Noda, M. Chapter Thirteen-Thyroid Hormone in the CNS: Contribution of Neuron-Glia Interaction. In Vitamins and Hormones;
  69. Litwack, G., Ed.; Thyroid Hormone; Academic Press: New York, NY, USA, 2018; Volume 106, pp. 313-331.
  70. Gould, E.; Butcher, L.L. Developing Cholinergic Basal Forebrain Neurons Are Sensitive to Thyroid Hormone. J. Neurosci. 1989, 9, 3347-3358. [CrossRef] · DOI
  71. Gould, E.; Frankfurt, M.; Westlind-Danielsson, A.; McEwen, B.S. Developing Forebrain Astrocytes Are Sensitive to Thyroid Hormone. Glia 1990, 3, 283-292. [CrossRef] · DOI
  72. Lima, F.R.; Gervais, A.; Colin, C.; Izembart, M.; Neto, V.M.; Mallat, M. Regulation of Microglial Development: A Novel Role for Thyroid Hormone. J. Neurosci. 2001, 21, 2028-2038. [CrossRef] · DOI
  73. Rodriguez-Peña, A.; Ibarrola, N.; Iñiguez, M.A.; Muñoz, A.; Bernal, J. Neonatal Hypothyroidism Affects the Timely Expression of Myelin-Associated Glycoprotein in the Rat Brain. J. Clin. Investig. 1993, 91, 812-818. [CrossRef] [PubMed] · DOI
  74. Ge, G.M.; Leung, M.T.Y.; Man, K.K.C.; Leung, W.C.; Ip, P.; Li, G.H.Y.; Wong, I.C.K.; Kung, A.W.C.; Cheung, C.-L. Maternal Thyroid Dysfunction During Pregnancy and the Risk of Adverse Outcomes in the Offspring: A Systematic Review and Meta-Analysis. J. Clin. Endocrinol. Metab. 2020, 105, 3821-3841. [CrossRef] [PubMed] · DOI
  75. Román, G.C.; Ghassabian, A.; Bongers-Schokking, J.J.; Jaddoe, V.W.V.; Hofman, A.; De Rijke, Y.B.; Verhulst, F.C.; Tiemeier, H. Association of Gestational Maternal Hypothyroxinemia and Increased Autism Risk. Ann. Neurol. 2013, 74, 733-742. [CrossRef] [PubMed] · DOI
  76. Chen, Z.-P.; Hetzel, B.S. Cretinism Revisited. Best. Pract. Res. Clin. Endocrinol. Metab. 2010, 24, 39-50. [CrossRef] · DOI
  77. Meerts, I.A.T.M.; Lilienthal, H.; Hoving, S.; van den Berg, J.H.J.; Weijers, B.M.; Bergman, Å.; Koeman, J.H.; Brouwer, A. Developmental Exposure to 4-Hydroxy-2,3,3 ′ ,4 ′ ,5-Pentachlorobiphenyl (4-OH-CB107): Long-Term Effects on Brain Development, Behavior, and Brain Stem Auditory Evoked Potentials in Rats. Toxicol. Sci. 2004, 82, 207-218. [CrossRef] · DOI
  78. Babić Leko, M.; Pleić, N.; Lešin, M.; Gunjača, I.; Torlak, V.; Škunca Herman, J.; Vatavuk, Z.; Punda, A.; Polašek, O.; Hayward, C.; et al. Association between Thyroid Function and Ocular Parameters. Biology 2022, 11, 1847. [CrossRef] · DOI
  79. Pontelli, R.C.N.; Souza, M.C.O.; Fantucci, M.Z.; de Andrade, M.; Rocha, E.M. The Role of Endocrine Disruptors in Ocular Surface Diseases. Med. Hypotheses 2019, 122, 157-164. [CrossRef] · DOI
  80. Yang, F.; Ma, H.; Ding, X.-Q. Thyroid Hormone Signaling in Retinal Development, Survival, and Disease. Vitam. Horm. 2018, 106, 333-349. [CrossRef] · DOI
  81. Chen, Z.-F.; Lin, Z.-C.; Lu, S.-Q.; Chen, X.-F.; Liao, X.-L.; Qi, Z.; Cai, Z. Azole-Induced Color Vision Deficiency Associated with Thyroid Hormone Signaling: An Integrated In Vivo, In Vitro, and In Silico Study. Environ. Sci. Technol. 2022, 56, 13264-13273. [CrossRef] · DOI
  82. Jiang, Y.; Zhang, S.; Zhang, X.; Li, N.; Zhang, Q.; Guo, X.; Chi, X.; Tong, M. Peptidomic Analysis of Zebrafish Embryos Exposed to Polychlorinated Biphenyls and Their Impact on Eye Development. Ecotoxicol. Environ. Saf. 2019, 175, 164-172. [CrossRef] [PubMed] · DOI
  83. Kilburn, K.H. Visual and Neurobehavioral Impairment Associated with Polychlorinated Biphenyls. Neurotoxicology 2000, 21, 489-499. [PubMed]
  84. Wang, Y.-P.; Hong, Q.; Qin, D.; Kou, C.-Z.; Zhang, C.-M.; Guo, M.; Guo, X.-R.; Chi, X.; Tong, M.-L. Effects of Embryonic Exposure to Polychlorinated Biphenyls on Zebrafish (Danio Rerio) Retinal Development. J. Appl. Toxicol. 2012, 32, 186-193. [CrossRef] [PubMed] · DOI
  85. Baumann, L.; Segner, H.; Ros, A.; Knapen, D.; Vergauwen, L. Thyroid Hormone Disruptors Interfere with Molecular Pathways of Eye Development and Function in Zebrafish. Int. J. Mol. Sci. 2019, 20, 1543. [CrossRef] · DOI
  86. Hasegawa, M.; Wada, H. Developmental Hypothyroidism Disrupts Visual Signal Detection Performance in Rats. Physiol. Behav. 2013, 112-113, 90-95. [CrossRef] · DOI
  87. Knudsen, E.I. Evolution of Neural Processing for Visual Perception in Vertebrates. J. Comp. Neurol. 2020, 528, 2888-2901. [CrossRef] · DOI
  88. Zoeller, R.T.; Bansal, R.; Parris, C. Bisphenol-A, an Environmental Contaminant That Acts as a Thyroid Hormone Receptor Antag- onist in Vitro, Increases Serum Thyroxine, and Alters RC3/Neurogranin Expression in the Developing Rat Brain. Endocrinology 2005, 146, 607-612. [CrossRef] · DOI
  89. Xiang, Y.; Xin, J.; Le, W.; Yang, Y. Neurogranin: A Potential Biomarker of Neurological and Mental Diseases. Front. Aging Neurosci. 2020, 12, 584743. [CrossRef] · DOI
  90. Diotel, N.; Charlier, T.D.; Lefebvre d'Hellencourt, C.; Couret, D.; Trudeau, V.L.; Nicolau, J.C.; Meilhac, O.; Kah, O.; Pellegrini, E. Steroid Transport, Local Synthesis, and Signaling within the Brain: Roles in Neurogenesis, Neuroprotection, and Sexual Behaviors. Front. Neurosci. 2018, 12, 84. [CrossRef] · DOI
  91. Blanc-Legendre, M.; Sire, S.; Christophe, A.; Brion, F.; Bégout, M.-L.; Cousin, X. Embryonic Exposures to Chemicals Acting on Brain Aromatase Lead to Different Locomotor Effects in Zebrafish Larvae. Environ. Toxicol. Pharmacol. 2023, 102, 104221. [CrossRef] · DOI
  92. Bortolato, M.; Godar, S.C.; Davarian, S.; Chen, K.; Shih, J.C. Behavioral Disinhibition and Reduced Anxiety-like Behaviors in Monoamine Oxidase B-Deficient Mice. Neuropsychopharmacology 2009, 34, 2746-2757. [CrossRef] [PubMed] · DOI
  93. Bortolato, M.; Shih, J.C. Behavioral Outcomes of Monoamine Oxidase Deficiency: Preclinical and Clinical Evidence. In International Review of Neurobiology;
  94. Youdim, M.B.H., Douce, P., Eds.; Monoamine Oxidase and their Inhibitors; Academic Press: Cambridge, MA, USA, 2011; Volume 100, pp. 13-42.
  95. Matsuda, S.; Matsuzawa, D.; Ishii, D.; Tomizawa, H.; Sutoh, C.; Nakazawa, K.; Amano, K.; Sajiki, J.; Shimizu, E. Effects of Perinatal Exposure to Low Dose of Bisphenol A on Anxiety like Behavior and Dopamine Metabolites in Brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 39, 273-279. [CrossRef] [PubMed] · DOI
  96. McRobb, F.M.; Sahagún, V.; Kufareva, I.; Abagyan, R. In Silico Analysis of the Conservation of Human Toxicity and Endocrine Disruption Targets in Aquatic Species. Environ. Sci. Technol. 2014, 48, 1964-1972. [CrossRef] [PubMed] 100. Zhang, Z.; Chen, K.; Shih, J.C.; Teng, C.T. Estrogen-Related Receptors-Stimulated Monoamine Oxidase B Promoter Activity Is Down-Regulated by Estrogen Receptors. Mol. Endocrinol. 2006, 20, 1547-1561. [CrossRef] 101. Dutta, H.M.; Arends, D.A. Effects of Endosulfan on Brain Acetylcholinesterase Activity in Juvenile Bluegill Sunfish. Environ. Res. 2003, 91, 157-162. [CrossRef] 102. Diamanti-Kandarakis, E.; Bourguignon, J.-P.; Giudice, L.C.; Hauser, R.; Prins, G.S.; Soto, A.M.; Zoeller, R.T.; Gore, A.C. Endocrine- Disrupting Chemicals: An Endocrine Society Scientific Statement. Endocr. Rev. 2009, 30, 293-342. [CrossRef] 103. Kutsuno, Y.; Hirashima, R.; Sakamoto, M.; Ushikubo, H.; Michimae, H.; Itoh, T.; Tukey, R.H.; Fujiwara, R. Expression of UDP- Glucuronosyltransferase 1 (UGT1) and Glucuronidation Activity toward Endogenous Substances in Humanized UGT1 Mouse Brain. Drug Metab. Dispos. 2015, 43, 1071. [CrossRef] 104. Ouzzine, M.; Gulberti, S.; Ramalanjaona, N.; Magdalou, J.; Fournel-Gigleux, S. The UDP-Glucuronosyltransferases of the Blood-Brain Barrier: Their Role in Drug Metabolism and Detoxication. Front. Cell. Neurosci. 2014, 8, 349. [CrossRef] 105. Sheng, Y.; Yang, H.; Wu, T.; Zhu, L.; Liu, L.; Liu, X. Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances. Front. Pharmacol. 2021, 12, 650027. [CrossRef] 106. Arambula, S.E.; McCarthy, M.M. Neuroendocrine-Immune Crosstalk Shapes Sex-Specific Brain Development. Endocrinology 2020, 161, bqaa055. [CrossRef] 107. · DOI · Paper page
  97. Blalock, J.E. A Molecular Basis for Bidirectional Communication between the Immune and Neuroendocrine Systems. Physiol. Rev. 1989, 69, 1-32. [CrossRef] [PubMed] 108. · DOI
  98. Buoso, E.; Masi, M.; Limosani, R.V.; Oliviero, C.; Saeed, S.; Iulini, M.; Passoni, F.C.; Racchi, M.; Corsini, E. Endocrine Disrupting Toxicity of Bisphenol A and Its Analogs: Implications in the Neuro-Immune Milieu. J. Xenobiotics 2025, 15, 13. [CrossRef] [PubMed] 109. Reddy, V.; McCarthy, M.; Raval, A.P. Xenoestrogens Impact Brain Estrogen Receptor Signaling during the Female Lifespan: A Precursor to Neurological Disease? Neurobiol. Dis. 2022, 163, 105596. [CrossRef] [PubMed] 110. · DOI
  99. He, D.-Y.; Neasta, J.; Ron, D. Epigenetic Regulation of BDNF Expression via the Scaffolding Protein RACK1. J. Biol. Chem. 2010, 285, 19043-19050. [CrossRef] 111. Cirillo, F.; Lappano, R.; Bruno, L.; Rizzuti, B.; Grande, F.; Guzzi, R.; Briguori, S.; Miglietta, A.M.; Nakajima, M.; Di Martino, M.T.; et al. AHR and GPER Mediate the Stimulatory Effects Induced by 3-Methylcholanthrene in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs). J. Exp. Clin. Cancer Res. 2019, 38, 335. [CrossRef] 112. Yan, S.; Ji, J.; Zhang, Z.; Imam, M.; Chen, H.; Zhang, D.; Wang, J. Targeting the Crosstalk between Estrogen Receptors and Membrane Growth Factor Receptors in Breast Cancer Treatment: Advances and Opportunities. Biomed. Pharmacother. 2024, 175, 116615. [CrossRef] 113. Masi, M.; Maddalon, A.; Iulini, M.; Linciano, P.; Galbiati, V.; Marinovich, M.; Racchi, M.; Corsini, E.; Buoso, E. Effects of Endocrine Disrupting Chemicals on the Expression of RACK1 and LPS-Induced THP-1 Cell Activation. Toxicology 2022, 480, 153321. [CrossRef] 114. Żabi ńska, M.; Wiśniewska, K.; Węgrzyn, G.; Pierzynowska, K. Exploring the Physiological Role of the G Protein-Coupled Estrogen Receptor (GPER) and Its Associations with Human Diseases. Psychoneuroendocrinology 2024, 166, 107070. [CrossRef] 115. Zheng, Y.; Wu, M.; Gao, T.; Meng, L.; Ding, X.; Meng, Y.; Jiao, Y.; Luo, P.; He, Z.; Sun, T.; et al. GPER-Deficient Rats Exhibit Lower Serum Corticosterone Level and Increased Anxiety-Like Behavior. Neural Plast. 2020, 2020, 8866187. [CrossRef] 116. Buoso, E.; Kenda, M.; Masi, M.; Linciano, P.; Galbiati, V.; Racchi, M.; Dolenc, M.S.; Corsini, E. Effects of Bisphenols on RACK1 Expression and Their Immunological Implications in THP-1 Cells. Front. Pharmacol. 2021, 12, 743991. [CrossRef] 117. Oudart, M.; Avila-Gutierrez, K.; Moch, C.; Dossi, E.; Milior, G.; Boulay, A.-C.; Gaudey, M.; Moulard, J.; Lombard, B.; Loew, D.; et al. The Ribosome-Associated Protein RACK1 Represses Kir4.1 Translation in Astrocytes and Influences Neuronal Activity. Cell. Rep. 2023, 42, 112456. [CrossRef] 118. Takahashi, M.; Komada, M.; Miyazawa, K.; Goto, S.; Ikeda, Y. Bisphenol A Exposure Induces Increased Microglia and Microglial Related Factors in the Murine Embryonic Dorsal Telencephalon and Hypothalamus. Toxicol. Lett. 2018, 284, 113-119. [CrossRef] [PubMed] 119. Brandl, S.; Reindl, M. Blood-Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models. Int. J. Mol. Sci. 2023, 24, 12699. [CrossRef] [PubMed] 120. Ahmadpour, D.; Mhaouty-Kodja, S.; Grange-Messent, V. Disruption of the Blood-Brain Barrier and Its Close Environment Following Adult Exposure to Low Doses of Di(2-Ethylhexyl)Phthalate Alone or in an Environmental Phthalate Mixture in Male Mice. Chemosphere 2021, 282, 131013. [CrossRef] [PubMed] 121. Alavian-Ghavanini, A.; Rüegg, J. Understanding Epigenetic Effects of Endocrine Disrupting Chemicals: From Mechanisms to Novel Test Methods. Basic Clin. Pharmacol. Toxicol. 2018, 122, 38-45. [CrossRef] 122. Rattan, S.; Flaws, J.A. The Epigenetic Impacts of Endocrine Disruptors on Female Reproduction across Generations. Biol. Reprod. 2019, 101, 635-644. [CrossRef] 123. Singleton, D.W.; Feng, Y.; Yang, J.; Puga, A.; Lee, A.V.; Khan, S.A. Gene Expression Profiling Reveals Novel Regulation by Bisphenol-A in Estrogen Receptor-Alpha-Positive Human Cells. Environ. Res. 2006, 100, 86-92. [CrossRef] 124. · DOI
  100. Walker, D.M.; Gore, A.C. Epigenetic Impacts of Endocrine Disruptors in the Brain. Front. Neuroendocrinol. 2017, 44, 1-26. [CrossRef] 125. Sheng, J.A.; Bales, N.J.; Myers, S.A.; Bautista, A.I.; Roueinfar, M.; Hale, T.M.; Handa, R.J. The Hypothalamic-Pituitary-Adrenal Axis: Development, Programming Actions of Hormones, and Maternal-Fetal Interactions. Front. Behav. Neurosci. 2021, 14, 601939. [CrossRef] 126. Coussons-Read, M.E. Effects of Prenatal Stress on Pregnancy and Human Development: Mechanisms and Pathways. Obstet. Med. 2013, 6, 52-57. [CrossRef] 127. Lazinski, M.J.; Shea, A.K.; Steiner, M. Effects of Maternal Prenatal Stress on Offspring Development: A Commentary. Arch. Womens Ment. Health 2008, 11, 363-375. [CrossRef] 128. Lund, I.O.; Hannigan, L.J.; Ask, H.; Askelund, A.D.; Hegemann, L.; Corfield, E.C.; Wootton, R.E.; Ahmadzadeh, Y.I.; Davey Smith, G.; McAdams, T.A.; et al. Prenatal Maternal Stress: Triangulating Evidence for Intrauterine Exposure Effects on Birth and Early Childhood Outcomes across Multiple Approaches. BMC Med. 2025, 23, 18. [CrossRef] [PubMed] 129. · DOI
  101. LeWinn, K.Z.; Stroud, L.R.; Molnar, B.E.; Ware, J.H.; Koenen, K.C.; Buka, S.L. Elevated Maternal Cortisol Levels during Pregnancy Are Associated with Reduced Childhood IQ. Int. J. Epidemiol. 2009, 38, 1700-1710. [CrossRef] [PubMed] 130. · DOI
  102. Dickerson, S.M.; Cunningham, S.L.; Gore, A.C. Prenatal PCBs Disrupt Early Neuroendocrine Development of the Rat Hypothala- mus. Toxicol. Appl. Pharmacol. 2011, 252, 36-46. [CrossRef] [PubMed] 140. · DOI · Paper page
  103. Buoso, E.; Galasso, M.; Ronfani, M.; Papale, A.; Galbiati, V.; Eberini, I.; Marinovich, M.; Racchi, M.; Corsini, E. The Scaffold Protein RACK1 Is a Target of Endocrine Disrupting Chemicals (EDCs) with Important Implication in Immunity. Toxicol. Appl. Pharmacol. 2017, 325, 37-47. [CrossRef] [PubMed] 151. · DOI
  104. Buoso, E.; Masi, M.; Galbiati, V.; Maddalon, A.; Iulini, M.; Kenda, M.; Sollner Dolenc, M.; Marinovich, M.; Racchi, M.; Corsini, E. Effect of Estrogen-Active Compounds on the Expression of RACK1 and Immunological Implications. Arch. Toxicol. 2020, 94, 2081-2095. [CrossRef] [PubMed] 152. · DOI
  105. Pahović, P.Š.; Iulini, M.; Maddalon, A.; Galbiati, V.; Buoso, E.; Dolenc, M.S.; Corsini, E. In Vitro Effects of Bisphenol Analogs on Immune Cells Activation and Th Differentiation. Endocr. Metab. Immune Disord. Drug Targets 2023, 23, 1750-1761. [CrossRef] 153. O'Brien, E.; Dolinoy, D.C.; Mancuso, P. Bisphenol A at Concentrations Relevant to Human Exposure Enhances Histamine and Cysteinyl Leukotriene Release from Bone Marrow-Derived Mast Cells. J. Immunotoxicol. 2014, 11, 84-89. [CrossRef] 154. Ménard, S.; Guzylack-Piriou, L.; Lencina, C.; Leveque, M.; Naturel, M.; Sekkal, S.; Harkat, C.; Gaultier, E.; Olier, M.; Garcia-Villar, R.; et al. Perinatal Exposure to a Low Dose of Bisphenol A Impaired Systemic Cellular Immune Response and Predisposes Young Rats to Intestinal Parasitic Infection. PLoS ONE 2014, 9, e112752. [CrossRef] 155. Clemente-Suárez, V.J.; Redondo-Flórez, L.; Rubio-Zarapuz, A.; Martín-Rodríguez, A.; Tornero-Aguilera, J.F. Microbiota Im- plications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches. Biomedicines 2024, 12, 221. [CrossRef] 156. Kandpal, M.; Indari, O.; Baral, B.; Jakhmola, S.; Tiwari, D.; Bhandari, V.; Pandey, R.K.; Bala, K.; Sonawane, A.; Jha, H.C. Dysbiosis of Gut Microbiota from the Perspective of the Gut-Brain Axis: Role in the Provocation of Neurological Disorders. Metabolites 2022, 12, 1064. [CrossRef] 157. Appleton, J. The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health. Integr. Med. 2018, 17, 28-32. 158. Kumar, A.; Pramanik, J.; Goyal, N.; Chauhan, D.; Sivamaruthi, B.S.; Prajapati, B.G.; Chaiyasut, C. Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options. Pharmaceuticals 2023, 16, 565. [CrossRef] 159. Caspani, G.; Swann, J. Small Talk: Microbial Metabolites Involved in the Signaling from Microbiota to Brain. Curr. Opin. Pharmacol. 2019, 48, 99-106. [CrossRef] 160. Al-Asmakh, M.; Anuar, F.; Zadjali, F.; Rafter, J.; Pettersson, S. Gut Microbial Communities Modulating Brain Development and Function. Gut Microbes 2012, 3, 366-373. [CrossRef] 161. · DOI
  106. Fellows, R.; Denizot, J.; Stellato, C.; Cuomo, A.; Jain, P.; Stoyanova, E.; Balázsi, S.; Hajnády, Z.; Liebert, A.; Kazakevych, J.; et al. Microbiota Derived Short Chain Fatty Acids Promote Histone Crotonylation in the Colon through Histone Deacetylases. Nat. Commun. 2018, 9, 105. [CrossRef] 162. Li, L.; Zhao, S.; Xiang, T.; Feng, H.; Ma, L.; Fu, P. Epigenetic Connection between Gut Microbiota-Derived Short-Chain Fatty Acids and Chromatin Histone Modification in Kidney Diseases. Chin. Med. J. 2022, 135, 1692-1694. [CrossRef] [PubMed] 163. Stein, R.A.; Riber, L. Epigenetic Effects of Short-Chain Fatty Acids from the Large Intestine on Host Cells. Microlife 2023, 4, uqad032. [CrossRef] [PubMed] 164. Xie, A.; Ensink, E.; Li, P.; Gordevičius, J.; Marshall, L.L.; George, S.; Pospisilik, J.A.; Aho, V.T.E.; Houser, M.C.; Pereira, P.A.B.; et al. Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms. Mov. Disord. 2022, 37, 1644-1653. [CrossRef] [PubMed] 165. · DOI
  107. Heijtz, R.D.; Wang, S.; Anuar, F.; Qian, Y.; Björkholm, B.; Samuelsson, A.; Hibberd, M.L.; Forssberg, H.; Pettersson, S. Normal Gut Microbiota Modulates Brain Development and Behavior. Proc. Natl. Acad. Sci. USA 2011, 108, 3047-3052. [CrossRef] 171. López-Moreno, A.; Torres-Sánchez, A.; Acuña, I.; Suárez, A.; Aguilera, M. Representative Bacillus Sp. AM1 from Gut Microbiota Harbor Versatile Molecular Pathways for Bisphenol A Biodegradation. Int. J. Mol. Sci. 2021, 22, 4952. [CrossRef] 172. Feng, P.; Ye, Z.; Kakade, A.; Virk, A.K.; Li, X.; Liu, P. A Review on Gut Remediation of Selected Environmental Contaminants: Possible Roles of Probiotics and Gut Microbiota. Nutrients 2019, 11, 22. [CrossRef] 173. Kong, Q.; Wang, B.; Tian, P.; Li, X.; Zhao, J.; Zhang, H.; Chen, W.; Wang, G. Daily Intake of Lactobacillus Alleviates Autistic-like Behaviors by Ameliorating the 5-Hydroxytryptamine Metabolic Disorder in VPA-Treated Rats during Weaning and Sexual Maturation. Food Funct. 2021, 12, 2591-2604. [CrossRef] 174. · DOI
  108. Kermath, B.A.; Thompson, L.M.; Jefferson, J.R.; Ward, M.H.B.; Gore, A.C. Transgenerational Effects of Prenatal Endocrine Disruption on Reproductive and Sociosexual Behaviors in Sprague Dawley Male and Female Rats. Toxics 2022, 10, 47. [CrossRef] [PubMed] 179. Popescu, M.; Feldman, T.B.; Chitnis, T. Interplay Between Endocrine Disruptors and Immunity: Implications for Diseases of Autoreactive Etiology. Front. Pharmacol. 2021, 12, 626107. [CrossRef] [PubMed] 180. · DOI
  109. Schug, T.T.; Janesick, A.; Blumberg, B.; Heindel, J.J. Endocrine Disrupting Chemicals and Disease Susceptibility. J. Steroid Biochem. Mol. Biol. 2011, 127, 204-215. [CrossRef] [PubMed] 181. Skinner, M.K.; Anway, M.D.; Savenkova, M.I.; Gore, A.C.; Crews, D. Transgenerational Epigenetic Programming of the Brain Transcriptome and Anxiety Behavior. PLoS ONE 2008, 3, e3745. [CrossRef] 182. · DOI · Paper page
  110. Tran, M.T.M.T.; Kuo, F.-C.; Low, J.-T.; Chuang, Y.-M.; Sultana, S.; Huang, W.-L.; Lin, Z.-Y.; Lin, G.-L.; Wu, C.-F.; Li, S.-S.; et al. Prenatal DEHP Exposure Predicts Neurological Disorders via Transgenerational Epigenetics. Sci. Rep. 2023, 13, 7399. [CrossRef] 183. Van Cauwenbergh, O.; Di Serafino, A.; Tytgat, J.; Soubry, A. Transgenerational Epigenetic Effects from Male Exposure to Endocrine-Disrupting Compounds: A Systematic Review on Research in Mammals. Clin. Epigenet. 2020, 12, 65. [CrossRef] 184. · DOI
  111. Crews, D.; Gillette, R.; Scarpino, S.V.; Manikkam, M.; Savenkova, M.I.; Skinner, M.K. Epigenetic Transgenerational Inheritance of Altered Stress Responses. Proc. Natl. Acad. Sci. USA 2012, 109, 9143-9148. [CrossRef] 185. Krishnan, K.; Rahman, S.; Hasbum, A.; Morales, D.; Thompson, L.M.; Crews, D.; Gore, A.C. Maternal Care Modulates Transgen- erational Effects of Endocrine-Disrupting Chemicals on Offspring Pup Vocalizations and Adult Behaviors. Horm. Behav. 2019, 107, 96-109. [CrossRef] 186. Gillette, R.; Miller-Crews, I.; Skinner, M.K.; Crews, D. Distinct Actions of Ancestral Vinclozolin and Juvenile Stress on Neural Gene Expression in the Male Rat. Front. Genet. 2015, 6, 56. [CrossRef] 187. Gillette, R.; Miller-Crews, I.; Nilsson, E.E.; Skinner, M.K.; Gore, A.C.; Crews, D. Sexually Dimorphic Effects of Ancestral Exposure to Vinclozolin on Stress Reactivity in Rats. Endocrinology 2014, 155, 3853-3866. [CrossRef] 188. · DOI · Paper page
  112. Hatcher, K.M.; Willing, J.; Chiang, C.; Rattan, S.; Flaws, J.A.; Mahoney, M.M. Exposure to Di-(2-Ethylhexyl) Phthalate Transgener- ationally Alters Anxiety-like Behavior and Amygdala Gene Expression in Adult Male and Female Mice. Physiol. Behav. 2019, 207, 7-14. [CrossRef] 189. Martini, M.; Corces, V.G.; Rissman, E.F. Mini-Review: Epigenetic Mechanisms That Promote Transgenerational Actions of Endocrine Disrupting Chemicals: Applications to Behavioral Neuroendocrinology. Horm. Behav. 2020, 119, 104677. [CrossRef] [PubMed] 190. · DOI
  113. Carbone, S.; Ponzo, O.J.; Gobetto, N.; Samaniego, Y.A.; Reynoso, R.; Moguilevsky, J.A.; Cutrera, R.A. Effect of Di(2-Ethylhexyl) Phthalate on the Neuroendocrine Regulation of Reproduction in Adult Male Rats and Its Relationship to Anxiogenic Behavior: Participation of GABAergic System. Hum. Exp. Toxicol. 2019, 38, 25-35. [CrossRef] [PubMed] 191. Chen, Y.C.; Yu, M.L.; Rogan, W.J.; Gladen, B.C.; Hsu, C.C. A 6-Year Follow-up of Behavior and Activity Disorders in the Taiwan Yu-Cheng Children. Am. J. Public Health 1994, 84, 415-421. [CrossRef] [PubMed] 192. · DOI
  114. Freire, C.; Amaya, E.; Gil, F.; Fernández, M.F.; Murcia, M.; Llop, S.; Andiarena, A.; Aurrekoetxea, J.; Bustamante, M.; Guxens, M.; et al. Prenatal Co-Exposure to Neurotoxic Metals and Neurodevelopment in Preschool Children: The Environment and Childhood (INMA) Project. Sci. Total Environ. 2018, 621, 340-351. [CrossRef] 193. Kim, S.; Eom, S.; Kim, H.-J.; Lee, J.J.; Choi, G.; Choi, S.; Kim, S.; Kim, S.Y.; Cho, G.; Kim, Y.D.; et al. Association between Maternal Exposure to Major Phthalates, Heavy Metals, and Persistent Organic Pollutants, and the Neurodevelopmental Performances of Their Children at 1 to 2 Years of Age-CHECK Cohort Study. Sci. Total Environ. 2018, 624, 377-384. [CrossRef] 194. Vuong, A.M.; Yolton, K.; Xie, C.; Webster, G.M.; Sjödin, A.; Braun, J.M.; Dietrich, K.N.; Lanphear, B.P.; Chen, A. Childhood Polybrominated Diphenyl Ether (PBDE) Exposure and Neurobehavior in Children at 8 Years. Environ. Res. 2017, 158, 677-684. [CrossRef] 195. Zhang, Q.; Chen, X.-Z.; Huang, X.; Wang, M.; Wu, J. The Association between Prenatal Exposure to Phthalates and Cognition and Neurobehavior of Children-Evidence from Birth Cohorts. NeuroToxicology 2019, 73, 199-212. [CrossRef] 196. León-Olea, M.; Martyniuk, C.J.; Orlando, E.F.; Ottinger, M.A.; Rosenfeld, C.S.; Wolstenholme, J.T.; Trudeau, V.L. Current Concepts in Neuroendocrine Disruption. Gen. Comp. Endocrinol. 2014, 203, 158-173. [CrossRef] [PubMed] 197. · DOI
  115. Mendola, P.; Buck, G.M.; Sever, L.E.; Zielezny, M.; Vena, J.E. Consumption of PCB-Contaminated Freshwater Fish and Shortened Menstrual Cycle Length. Am. J. Epidemiol. 1997, 146, 955-960. [CrossRef] [PubMed] 198. Dallaire, R.; Dewailly, É.; Ayotte, P.; Forget-Dubois, N.; Jacobson, S.W.; Jacobson, J.L.; Muckle, G. Exposure to Organochlorines and Mercury through Fish and Marine Mammal Consumption: Associations with Growth and Duration of Gestation among Inuit Newborns. Environ. Int. 2013, 54, 85-91. [CrossRef] [PubMed] 199. Buck Louis, G.M. Persistent Environmental Pollutants and Couple Fecundity: An Overview. Reproduction 2014, 147, R97-R104. [CrossRef] 200. Fourrier, J.; Deschamps, M.; Droin, L.; Alaux, C.; Fortini, D.; Beslay, D.; Conte, Y.L.; Devillers, J.; Aupinel, P.; Decourtye, A. Larval Exposure to the Juvenile Hormone Analog Pyriproxyfen Disrupts Acceptance of and Social Behavior Performance in Adult Honeybees. PLoS ONE 2015, 10, e0132985. [CrossRef] 201. · DOI
  116. Nilsen, E.; Smalling, K.L.; Ahrens, L.; Gros, M.; Miglioranza, K.S.B.; Picó, Y.; Schoenfuss, H.L. Critical Review: Grand Challenges in Assessing the Adverse Effects of Contaminants of Emerging Concern on Aquatic Food Webs. Environ. Toxicol. Chem. 2019, 38, 46-60. [CrossRef] 202. Ward, J.L.; Korn, V.; Auxier, A.N.; Schoenfuss, H.L. Temperature and Estrogen Alter Predator-Prey Interactions between Fish Species. Integr. Org. Biol. 2020, 2, obaa008. [CrossRef] 203. Eikenaar, C.; Müller, F.; Leutgeb, C.; Hessler, S.; Lebus, K.; Taylor, P.D.; Schmaljohann, H. Corticosterone and Timing of Migratory Departure in a Songbird. Proc. Biol. Sci. 2017, 284, 20162300. [CrossRef] 204. · DOI
  117. Deem, S.L.; Holliday, D.K. Chapter 21-Impacts from Endocrine Disrupting Chemicals on Wildlife Health-A One Health Challenge. In Fowler' s Zoo and Wild Animal Medicine Current Therapy, Volume 10;
  118. Miller, E., Lamberski, N., Calle, P., Eds.; W.B. Saunders: New Delhi, India, 2023; pp. 131-136; ISBN 978-0-323-82852-9. 205.
  119. Godfray, H.C.J.; Stephens, A.E.A.; Jepson, P.D.; Jobling, S.; Johnson, A.C.; Matthiessen, P.; Sumpter, J.P.; Tyler, C.R.; McLean, A.R. A Restatement of the Natural Science Evidence Base on the Effects of Endocrine Disrupting Chemicals on Wildlife. Proc. R. Soc. B Biol. Sci. 2019, 286, 20182416. [CrossRef] 206. Zhou, J.; Cai, Z.-H.; Zhu, X.-S. Are Endocrine Disruptors among the Causes of the Deterioration of Aquatic Biodiversity? Integr. Environ. Assess. Manag. 2010, 6, 492-498. [CrossRef] 207. Moosa, A.; Shu, H.; Sarachana, T.; Hu, V.W. Are Endocrine Disrupting Compounds Environmental Risk Factors for Autism Spectrum Disorder? Horm. Behav. 2018, 101, 13-21. [CrossRef] 208. Jankowska, A.; Pola ńska, K.; Koch, H.M.; Pälmke, C.; Waszkowska, M.; Sta ńczak, A.; Wesołowska, E.; Hanke, W.; Bose-O'Reilly, S.; Calamandrei, G.; et al. Phthalate Exposure and Neurodevelopmental Outcomes in Early School Age Children from Poland. Environ. Res. 2019, 179, 108829. [CrossRef] 209. Chevrier, C.; Warembourg, C.; Le Maner-Idrissi, G.; Lacroix, A.; Dardier, V.; Le Sourn-Bissaoui, S.; Rouget, F.; Monfort, C.; Gaudreau, E.; Mercier, F.; et al. Childhood Exposure to Polybrominated Diphenyl Ethers and Neurodevelopment at Six Years of Age. NeuroToxicology 2016, 54, 81-88. [CrossRef] [PubMed] 210. · DOI
  120. Cunha, Y.G.d.O.; Amaral, G.C.B.d.; Felix, A.A.; Blumberg, B.; Amato, A.A. Early-Life Exposure to Endocrine-Disrupting Chemicals and Autistic Traits in Childhood and Adolescence: A Systematic Review of Epidemiological Studies. Front. Endocrinol. 2023, 14, 1184546. [CrossRef] [PubMed] 211. · DOI
  121. Coady, K.K.; Biever, R.C.; Denslow, N.D.; Gross, M.; Guiney, P.D.; Holbech, H.; Karouna-Renier, N.K.; Katsiadaki, I.; Krueger, H.; Levine, S.L.; et al. Current Limitations and Recommendations to Improve Testing for the Environmental Assessment of Endocrine Active Substances. Integr. Environ. Assess. Manag. 2017, 13, 302-316. [CrossRef] [PubMed] 212. · DOI
  122. Lagunas-Rangel, F.A.; Linnea-Niemi, J.V.; Kudłak, B.; Williams, M.J.; Jönsson, J.; Schiöth, H.B. Role of the Synergistic Interactions of Environmental Pollutants in the Development of Cancer. Geohealth 2022, 6, e2021GH000552. [CrossRef] 213. Vandenberg, L.N. Non-Monotonic Dose Responses in Studies of Endocrine Disrupting Chemicals: Bisphenol A as a Case Study. Dose Response 2013, 12, 259-276. [CrossRef] 214. · DOI
  123. Burton, N.O.; Greer, E.L. Multigenerational Epigenetic Inheritance: Transmitting Information across Generations. Semin. Cell Dev. Biol. 2022, 127, 121-132. [CrossRef] 215. Chakravarty, A.K.; Jarosz, D.F. More than Just a Phase: Prions at the Crossroads of Epigenetic Inheritance and Evolutionary Change. J. Mol. Biol. 2018, 430, 4607-4618. [CrossRef] 216. Peng, D.; Wang, C.; Li, K.-L.; Gan, Z.-X.; Li, Y.-H.; Wang, H.-W.; Li, Q.-Y.; Liu, X.-W.; Sun, H.-Y.; Jing, Y.-Y.; et al. The Establishment of Transgenerational Epigenetic Inheritance in the C. elegans Germline Is Mediated by Lipid Metabolism. bioRxiv 2020. [CrossRef] 217. · DOI
  124. Kumar, V.; Deepika, D.; Sharma, R.P. Integrated Translation Framework for Endocrine Disruptors in the Area of Computational Toxicology. In Challenges in Endocrine Disruptor Toxicology and Risk Assessment; The Royal Society of Chemistry: Cambridge, UK, 2020. 218.
  125. Bornehag, C.-G.; Engdahl, E.; Unenge Hallerbäck, M.; Wikström, S.; Lindh, C.; Rüegg, J.; Tanner, E.; Gennings, C. Prenatal Exposure to Bisphenols and Cognitive Function in Children at 7 Years of Age in the Swedish SELMA Study. Environ. Int. 2021, 150, 106433. [CrossRef] 219. · DOI
  126. Özel, F.; Stratmann, M.; Lindh, C.; Gennings, C.; Bornehag, C.-G.; Rüegg, J. Prenatal Exposure to Phthalates and Gender-Specific Play Behavior at Seven Years of Age in the SELMA Study. Environ. Int. 2023, 178, 108029. [CrossRef] 220. · DOI · Paper page
  127. Hyland, C.; Mora, A.M.; Kogut, K.; Calafat, A.M.; Harley, K.; Deardorff, J.; Holland, N.; Eskenazi, B.; Sagiv, S.K. Prenatal Exposure to Phthalates and Neurodevelopment in the CHAMACOS Cohort. Environ. Health Perspect. 2019, 127, 107010. [CrossRef · DOI

Cited by

Sorted by citations

Authors
Damiano, A., Caioni, G., D’Addario, C., Merola, C., Francioso, A., & Amorena, M.
Affiliations
University of Teramo (IT)
Corresponding author
Caioni, Giulia
Venue
Stresses
Publisher
MDPI AG
Published
2025-08-01
Volume
5
Issue
3
Pages
46
ISSN
2673-7140 (ISSN-L)
OpenAlex
W4412940521
Cited by
7
References
9
Citations by year
2026: 5 · 2025: 2
FWCI
2.99
Type
journal article
Language
en
Open access
Locations
  • Stresses (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UniTERAMO Research Catalog (University of Teramo) (submittedVersion)
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
Keywords
endocrine disruptors, brain development, epigenetic modifications, DNA methylation, histone acetylation, transgenerational effects, gut-brain axis, gut microbiota, immunomodulation, behavioral phenotypes, cognitive and emotional development, social behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review